Skip to Main Content

Author Details

Daniel H Hovelson
Michigan Center for Translational Pathology, University of Michigan ann arbor
2014
48
26
PMIDPaper TitleJournal TitlePublished Year
36750617Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.Commun Med (Lond)2023
37497337Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.Cancer Res Commun2023
35233056Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.NPJ Precis Oncol2022
33812851Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer.Eur Urol Oncol2022
35220606Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.J Pathol2022
34476329Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.JCO Precis Oncol2021
34454112Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling Test.J Mol Diagn2021
31705765Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.Genes Chromosomes Cancer2020
31969336<i>CDKN1B</i> Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer.Clin Cancer Res2020
32017048Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.Clin Pharmacol Ther2020
32015231A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target.J Clin Invest2020
30610106Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma.Mol Cancer Res2019
32914029Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer.JCO Precis Oncol2019
31276932Circulating Tumor Cell-Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer.Neoplasia2019
30475217Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronism.Endocr Relat Cancer2019
29233927Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms.Cancer Res2018
29980330Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell Carcinoma.Eur Urol2018
30033047Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.Eur Urol2018
30385730Transcriptomic heterogeneity in multifocal prostate cancer.JCI Insight2018
29430509Molecular Correlates of <i>In Vitro</i> Responses to Dacomitinib and Afatinib in Bladder Cancer.Bladder Cancer2018
28031426Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer.Clin Cancer Res2017
28165631A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.Histopathology2017
28403382Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases.JAMA Dermatol2017
28187516Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.Clin Pharmacol Ther2017
29264530Aldosterone-Producing Cell Clusters Frequently Harbor Somatic Mutations and Accumulate With Age in Normal Adrenals.J Endocr Soc2017
29163793Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.Oncotarget2017
28775129Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable <i>FGFR3</i> Amplifications.Mol Cancer Res2017
27984508Characterization of ADME gene variation in 21 populations by exome sequencing.Pharmacogenet Genomics2017
28002793Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.Oncotarget2017
25985884Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.Eur Urol2016
26568296Intra-tumor genetic heterogeneity in rectal cancer.Lab Invest2016
27664537Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.Hum Pathol2016
27635946Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.Am J Surg Pathol2016
27749331The Role of Next-Generation Sequencing in Castration-Resistant Prostate Cancer Treatment.Cancer J2016
27067779Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.Hum Pathol2016
26743471Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.Mod Pathol2016
26849095Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencing.Head Neck2016
27102345Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.Mod Pathol2016
25593300Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.Mol Cancer Res2015
26670561Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy.Cancer Res2015
26444865Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment.J Hematol Oncol2015
26181193Next-Generation Sequencing of Tubal Intraepithelial Carcinomas.JAMA Oncol2015
26240369Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.Proc Natl Acad Sci U S A2015
25925381Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.Neoplasia2015
25735316Integrative molecular profiling of routine clinical prostate cancer specimens.Ann Oncol2015
25502898Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma.Virchows Arch2015
24728188No large-effect low-frequency coding variation found for myocardial infarction.Hum Mol Genet2014
24633158Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk.Nat Genet2014
  • 1 - 48 of 48

Recommended Authors

Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 16
Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 5
Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 2
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 13
Ritika Kundra
Memorial Sloan Kettering Cancer Center
Career Start Year 2016
Number of shared co-authors 16
Takafumi N Yamaguchi
University of California los angeles
Career Start Year 2015
Number of shared co-authors 1
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Helio A Costa
Stanford University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Erica K Barnell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 5
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 2
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 6
Emilie Lalonde
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 2
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 33
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 11
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Alexander W Wyatt
University of British Columbia
Career Start Year 2007
Number of shared co-authors 20
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 0
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 16
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 2
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 0
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 0
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 38
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 3
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 5
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 18
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 1
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 13
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 34
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 32

Collaborators

Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 43
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 8
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 8
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 8
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 6
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 5
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 5
Simpa S Salami
University of Michigan Medical School ann arbor
Co-authored papers 5
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 4
Suresh Nair
Lehigh Valley Topper Cancer Institute
Co-authored papers 3
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Co-authored papers 3
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 3
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 3
Muneesh Tewari
University of Michigan ann arbor
Co-authored papers 3
Gon??alo R Abecasis
Regeneron Pharmaceuticals Inc.
Co-authored papers 3
Kathleen A Cooney
Duke University School of Medicine, and the Duke Cancer Institute
Co-authored papers 3
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 3
Ryan Dittamore
Decipher Biosciences Inc.
Co-authored papers 3
Peter Kuhn
University of Tubingen
Co-authored papers 2
Arne Gruen
Charite-University Hospital Berlin
Co-authored papers 2
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 2
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
Kristian Hveem
Co-authored papers 2
Robert L Grossman
University of Chicago
Co-authored papers 2
AmirAli Talasaz
University of California San Diego Moores Cancer Center
Co-authored papers 2
Tom Wilsgaard
Co-authored papers 2
Phillip G Febbo
Illumina Inc.
Co-authored papers 2
Jake Vinson
Prostate Cancer Clinical Trials Consortium (PCCTC)
Co-authored papers 2
Anand Kolatkar
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
Inger Njølstad
Co-authored papers 2
Release 1.2